/CAH
Cardinal Health, Inc.
CAH • NYSECAH • NYSE • Healthcare
$216.36-0.57%-1.23
$216.36-0.57%(-1.23)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
82Bullish
Risk
95Low Risk
Momentum
76Positive
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
3.7%▲0.4pp
Revenue after COGS
Operating
1.0%▲0.5pp
After operating expenses
Net
0.7%▲0.3pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
25.9
Price vs earnings
EV/EBITDA
14.8
Enterprise value
FCF Yield
4.6%
Cash generation
Earnings Yield
3.9%
Inverse of P/E
Capital Efficiency
-11
GoAI Quality ScorePoor
ROEReturn on Equity
-56.1%Weak
ROAReturn on Assets
2.9%Fair
ROICReturn on Invested Capital
11.4%Strong
Financial Health
Current RatioWeak
0.94
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
1.76x
Debt repayment capacity (<3x)
Income QualityStrong
1.53
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B |
| Gross Profit | $8.17B | $7.41B | $6.89B | $6.48B | $6.78B |
| Gross Margin | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% |
| Operating Income | $2.27B | $1.24B | $752.00M | -$607.00M | $472.00M |
| Net Income | $1.56B | $852.00M | $330.00M | -$938.00M | $611.00M |
| Net Margin | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% |
| EPS | $6.48 | $3.48 | $1.26 | -$3.34 | $2.09 |
Average Price Target
$252.33▲ 16.6% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Cardinal Health, Inc., the average price target is $252.33, with a high forecast of $275.00 and a low forecast of $220.00. The average price target represents a 16.6% increase from the current price of $216.36.
Highest
$275.00
Average
$252.33
Lowest
$220.00
Rating Distribution
Strong Buy
0
0%
Buy
18
55%
Hold
15
45%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Barclays● Maintain
Overweight
2026-02-24JP Morgan● Maintain
Neutral
2026-02-10Wells Fargo● Maintain
Overweight
2026-02-10Mizuho● Maintain
Outperform
2026-02-06Morgan Stanley● Maintain
Overweight
2026-01-29Wells Fargo● Maintain
Overweight
2026-01-15Citigroup▲ Upgrade
Neutral→Buy
2026-01-09Wells Fargo● Maintain
Overweight
2025-11-05Mizuho● Maintain
Outperform
2025-11-04TD Cowen● Maintain
Buy
2025-11-03Earnings History & Surprises
BEAT RATE
83%
Last 18 quarters
AVG SURPRISE
+9.2%
EPS vs Estimate
BEATS / MISSES
15/3
Last 18 quarters
LATEST EPS
$2.63
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+12.4%
$2.63 vs $2.34
Q4 '25
+17.0%
$2.55 vs $2.18
Q3 '25
+2.0%
$2.08 vs $2.04
Q2 '25
+8.3%
$2.35 vs $2.17
Q1 '25
+10.9%
$1.93 vs $1.74
Q4 '24
+16.0%
$1.88 vs $1.62
Q3 '24
+6.4%
$1.84 vs $1.73
Q2 '24
+6.7%
$2.08 vs $1.95
Q1 '24
+13.7%
$1.82 vs $1.60
Q4 '23
+23.6%
$1.73 vs $1.40
Q3 '23
+4.7%
$1.55 vs $1.48
Q2 '23
+16.8%
$1.74 vs $1.49
No investor questions available.
Latest News
No news available